Assessment of the Association of Oct3/4 With Glut1 and Cd105 in Oral Squamous Cell Carcinoma Using Dual Immunohistochemistry Publisher Pubmed



Derakhshan S^{1, 2} ; Mahdavi N¹ ; Kardouni Khoozestani N¹ ; Nasr Esfahani B³ ; Heidarian F³ ; Rahrotaban S⁴ ; Abdolrahmani A⁵ Show Affiliations
Source: BMC Oral Health Published:2022

Abstract

Background: Oral squamous cell carcinoma (OSCC) is the most common cancer affecting the oral and maxillofacial region. This study aimed to investigate the role of cancer stem cells (CSCs) in angiogenesis and hypoxic response in OSCC. Methods: This retrospective observational study evaluated 56 cases of OSCC using dual immunohistochemistry. Octamer-binding transcription factor 3/4 (OCT3/4) marker was used to evaluate CSC activity. Glucose transporter 1 (GLUT1) marker was used to evaluate the hypoxic response and angiogenesis, while endoglin (CD105) was used to evaluate the late stage of angiogenesis and blood vessel formation. Results: Co-expression of OCT3/4 and GLUT1 was noted in 11 of 12 patients with grade III OSCC. However, we did not observe co-expression of these markers in 13 of 22 patients with grade I OSCC. Although we observed a significant correlation between co-expression of GLUT1 and OCT3/4 and tumor grade, there was no significant correlation between co-expression of OCT3/4 and CD105 and different grades of OSCC. Conclusions: CSCs could play important roles in the initial stages of hypoxic response and angiogenesis. Our result reported that in higher grades of OSCC, GLUT1 as a first response to hypoxic situations might be a result of CSCs. Further studies are required to discover other biomarkers, their roles, and associated pathways of CSCs in OSCC. © 2022, The Author(s).